Results 121 to 130 of about 292,402 (288)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

ESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi, Mostafa Eslamiyeh, Amin Mansoori, Eisa Nazar, Maryam Alinezhad‐Namaghi, Reza Rezvani, Majid Ghayour‐Mobarhan, Habibollah Esmaily, Mohsen Moohebati, Gordon A. Ferns, Mark Ghamsary   +10 more
wiley   +1 more source

Anti‐Malondialdehyde Low‐Density Lipoprotein Antibodies and Valvular Calcification: A Substudy of the SCOT‐HEART Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Coronary computed tomography–derived valve calcification is becoming increasingly important in the multi‐modality assessment of valvular disease, especially in aortic and mitral valve disease.
Adam Hartley, Michelle C. Williams, Amit Kaura, Sarah Verhemel, Mikhail Caga‐Anan, Damini Dey, Marc R. Dweck, Dorian O. Haskard, Michael Joner, Manuel Mayr, David E. Newby, Ramzi Y. Khamis   +11 more
doaj   +1 more source

Harrell’s C index according to the Cox models (Model 1: Ln free PCS+aortic calcification+CRP+Hb; Model 2: Ln free IS +aortic calcification+CRP+Hb; Model 3: Ln free PCG +aortic calcification+CRP+Hb).

, 2013
Harrell’s C index according to the Cox models (Model 1: Ln free PCS+aortic calcification+CRP+Hb; Model 2: Ln free IS +aortic calcification+CRP+Hb; Model 3: Ln free PCG +aortic calcification+CRP+Hb).
Gabriel Choukroun (425928), Raymond Vanholder (138561), Lucie Desjardins (425927), Griet Glorieux (138530), Aurelie Lenglet (5655421), Sophie Liabeuf (138541), Momar Diouf (425925), Eva Schepers (425926), Ziad A. Massy (126268)   +8 more
core   +1 more source

Calcific Aortic Stenosis

Journal of the Royal College of Physicians of London, 1983
C, Wren, M C, Petch
openaire   +2 more sources

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats

ESC Heart Failure, Volume 12, Issue 2, Page 1304-1315, April 2025.
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén, Bård Andre Bendiksen, Kaja Knudsen Bergo, Emil Knut Stenersen Espe, Gary McGinley, Almira Hasic, Ida Marie Hauge‐Iversen, Hege Katrin Ugland, Xin Shen, Michael Frisk, Nishani S. Mabotuwana, William E. Louch, Rizwan I. Hussain, Lili Zhang, Ivar Sjaastad, Alessandro Cataliotti, Geir Christensen   +16 more
wiley   +1 more source

Automated quantification of abdominal aortic calcification using 3D nnU-Net: a novel approach to assess AAA rupture risk

BMC Medical Imaging
Background Abdominal aortic aneurysms (AAA) pose a serious rupture risk, heightened by aortic calcification. Traditional calcification scoring methods are slow and require expertise.
Yuan-Lin Luo, Yi-Fan Liu, Zhi Huang, Chu Wang, Ling-Yue Zhang, Shui-Chuan Huang   +5 more
doaj   +1 more source